Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane gamma-carboxyglutamic acid protein 2 (PRRG2) is a membrane protein encoded by the PRRG2 gene. It comprises an N-terminal gamma-carboxyglutamic acid (Gla) domain, typically exposed extracellularly, and tandem Pro/Leu-Pro-Xaa-Tyr (PY) motifs at the C-terminal, which are cytoplasmic. The PY motifs interact with WW domain-containing proteins (e.g., YAP1), suggesting a possible role in intracellular signal transduction and protein-protein interactions. PRRG2 is widely expressed as a single-pass transmembrane protein but is not currently classified as a therapeutic target, receptor, enzyme, or transporter. While genetic studies link the PRRG2 locus to certain syndromes and vitamin K-dependent pathways, its direct molecular or clinical function remains unclear[1][2][6][7].
Not applicable; since no drugs interact with PRRG2, mechanisms for drug modulation are not described[2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane gamma-carboxyglutamic acid protein 2 (PRRG2).